Back
Day Range
$20.81
$22.85
52-Week Range
$12.56
$26.30
Volume
318,751
50D / 200D Avg
$18.41
/
$16.37
Prev Close
$22.10
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -19.6 | 0.4 |
| P/B | 17.6 | 2.9 |
| ROE % | -74.5 | 3.7 |
| Net Margin % | -20794.6 | 3.9 |
| Rev Growth 5Y % | -29.5 | 10.0 |
| D/E | 0.1 | 0.2 |
Analyst Price Target
Hold
$30.00
+43.3%
Forward EPS
-$1.18
Est. Revenue
3.2 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$0.39
$0.32 – $0.46
|
180 M | 1 |
| FY2029 |
-$0.31
-$0.37 – -$0.25
|
94 M | 1 |
| FY2028 |
-$0.79
-$0.94 – -$0.64
|
41 M | 1 |
Key Takeaways
Revenue declined -29.51% annually over 5 years
Debt/Equity of 0.09 — conservative balance sheet
Negative free cash flow of -54.44M
Capital intensive — 90.00% of revenue goes to capex
Growth
Revenue Growth (5Y)
-29.51%
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-74.45%
ROIC-65.43%
Net Margin-20794.57%
Op. Margin-21982.57%
Safety
Debt / Equity
0.09
Current Ratio10.53
Interest Coverage0.00
Valuation
P/E Ratio
-19.55
P/B Ratio17.64
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -29.51% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 350,000.0 | Net Income (TTM) | -72.78M |
| ROE | -74.45% | ROA | -75.72% |
| Gross Margin | -360.00% | Operating Margin | -21982.57% |
| Net Margin | -20794.57% | Free Cash Flow (TTM) | -54.44M |
| ROIC | -65.43% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.09 | Current Ratio | 10.53 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -19.55 | P/B Ratio | 17.64 |
| P/S Ratio | 4065.75 | PEG Ratio | -0.73 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.42B | Enterprise Value | 1.35B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 350,000.0 | 0.0 | 0.0 | 700,000.0 | 1.42M |
| Net Income | -72.78M | -53.59M | -42.21M | -58.51M | -63.66M |
| EPS (Diluted) | -1.08 | -0.92 | -0.88 | -1.72 | -2.28 |
| Gross Profit | -1.26M | 0.0 | -1.21M | -11.24M | -550,000.0 |
| Operating Income | -76.94M | -56.26M | -43.57M | -58.06M | -63.01M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 96.11M | 132.46M | 59.15M | 77.88M | 54.25M |
| Total Liabilities | 15.46M | 17.60M | 14.79M | 80.13M | 18.56M |
| Shareholders' Equity | 80.66M | 114.86M | 44.36M | -2.25M | 35.69M |
| Total Debt | 7.53M | 8.90M | 9.14M | 75.96M | 11.25M |
| Cash & Equivalents | 80.74M | 118.04M | 44.37M | 61.14M | 28.61M |
| Current Assets | 83.42M | 119.45M | 45.33M | 62.15M | 36.63M |
| Current Liabilities | 7.92M | 10.06M | 6.71M | 5.98M | 8.52M |